Trial Profile
An open label study to investigate the effect of multiple dose ACT-064992 on the pharmacokinetics and pharmacodynamics of single dose warfarin in healthy male subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Aug 2014
Price :
$35
*
At a glance
- Drugs Macitentan (Primary) ; Warfarin
- Indications Pulmonary arterial hypertension
- Focus Pharmacodynamics; Pharmacokinetics
- 11 Aug 2014 New trial record